REVERSIBILITY OF EXOGENOUS CORTICOSTEROID-INDUCED BONE LOSS

被引:0
|
作者
RIZZATO, G [1 ]
MONTEMURRO, L [1 ]
机构
[1] NIGUARDA HOSP, SARCOID CLIN, MILAN, ITALY
关键词
BONE MINERAL CONTENT; CORTICOSTEROID-INDUCED OSTEOPOROSIS; OSTEOPENIA; SARCOIDOSIS;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Osteoporosis is not usually considered to be reversible, as it is a consequence of the ageing process. However, an improvement of bone mineral density after successful surgery in Cushing's syndrome has been shown in several reports. The question of reversibility of exogenous corticosteroid-induced osteoporosis is, as vet, unanswered, possibly because of the difficulty in discontinuing steroids after long-term use. We describe six patients, all under 45 yrs of age, with chronic long-standing sarcoidosis, in whom long-term prednisone therapy resulted in 15+/-7% bone loss, as evaluated by quantitative computed tomography. This side-effect appeared fully reversible after prednisone withdrawal. This report of the reversibility of exogenous corticosteroid-induced bone loss needs confirmation in elderly people, where the capacity for recovery of bone mass could be reduced. Such potential for recovery may have implications for the pattern of use of corticosteroids.
引用
收藏
页码:116 / 119
页数:4
相关论文
共 50 条
  • [11] INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS
    ADACHI, JD
    CRANNEY, A
    GOLDSMITH, CH
    BENSEN, WG
    BIANCHI, F
    CIVIDINO, A
    CRAIG, GL
    KAMINSKA, E
    SEBALDT, RJ
    PAPAIOANNOU, A
    BORATTO, M
    GORDON, M
    STEELE, M
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (10) : 1922 - 1926
  • [12] BONE HISTOMORPHOMETRY IN CORTICOSTEROID-INDUCED OSTEOPENIA
    FAVINI, P
    ORTOLANI, S
    CORGHI, E
    COLOMBO, B
    VIGO, PL
    POLLI, E
    CALCIFIED TISSUE INTERNATIONAL, 1982, 34 (06) : 582 - 582
  • [13] INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS
    ADACHI, JD
    BENSEN, WG
    BIANCHI, F
    CIVIDINO, A
    CRAIG, GL
    CRANNEY, A
    KAMINSKA, E
    PAPAIOANNOU, A
    SEBALDT, RJ
    BORRATTO, M
    GORDON, M
    STEELE, M
    GOLDSMITH, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S325 - S325
  • [14] INTERMITTENT CYCLIC ETIDRONATE THERAPY (ICT) PREVENTS CORTICOSTEROID-INDUCED BONE LOSS
    ADACHI, JD
    BIANCHI, F
    CIVIDINO, A
    CRAIG, GL
    CRANNEY, A
    KAMINSKA, E
    PAPAIOANNOU, A
    SEBALDT, RJ
    BORRATTO, M
    GORDON, M
    STEELE, M
    GOLDSMITH, C
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S51 - S51
  • [15] Calcium and vitamin D therapy in corticosteroid-induced bone loss: What is the evidence?
    Adachi, JD
    Ioannidis, G
    CALCIFIED TISSUE INTERNATIONAL, 1999, 65 (04) : 332 - 336
  • [16] Calcium and Vitamin D Therapy in Corticosteroid-Induced Bone Loss: What is the Evidence?
    J. D. Adachi
    G. Ioannidis
    Calcified Tissue International, 1999, 65 : 332 - 336
  • [17] Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss
    Roux, C
    Oriente, P
    Laan, R
    Hughes, RA
    Ittner, J
    Goemaere, S
    Di Munno, O
    Pouillès, JM
    Horlait, S
    Corter, B
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04): : 1128 - 1133
  • [18] Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients
    Herrala, J
    Puolijoki, H
    Liippo, K
    Raitio, M
    Impivaara, O
    Tala, E
    Nieminen, MM
    BONE, 1998, 22 (05) : 577 - 582
  • [19] Bone microarchitecture in males with corticosteroid-induced osteoporosis
    D. Chappard
    N. Josselin
    C. Rougé-Maillart
    E. Legrand
    M. F. Baslé
    M. Audran
    Osteoporosis International, 2007, 18 : 487 - 494
  • [20] Bone microarchitecture in males with corticosteroid-induced osteoporosis
    Chappard, D.
    Josselin, N.
    Rouge-Maillart, C.
    Legrand, E.
    Basle, M. F.
    Audran, M.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 (04) : 487 - 494